Collection's Items (Sorted by Submit Date in Descending order): 61 to 80 of 201
| Preview | Issue Date | Title | Author(s) |
| 2024-06 | EXAMINING ML ALGORITHMS FOR PARKINSON'S DETECTION THROUGH SPEECH DATASETS : A COMPARATIVE ANALYSIS | KADYAN, SHIKHA |
| 2024-06 | EXPLORING THE POTANTIAL OF Ziziphus jujuba IN ARTERIOSCLEROSIS: A NETWORK PHARMACOLOGY APPROACH | PANDEY, DEEKSHA |
| 2024-06 | EXPLORING THE POTENTIAL OF Morindia citrifolia IN TUBERCULOSIS: A NETWORK PHARMACOLOGICAL APPROACH | SHARMA, ANJALI |
| 2024-06 | TARGETING YIN-YANG 1 INFLAMMATORY PATHWAY AS AN ALTERNATIVE TO MITIGATE THE SYMPTOMS OF MDD | SINGH, ADITI |
| 2024-06 | INNOVATIVE THERAPEUTICS FOR NEURODEGENERATIVE DISEASES : COMPUTATIONAL IDENTIFICATION OF ASK1 INHIBITORS FROM DIVERSE COMPOUND LIBRARIES | PALLAVI |
| 2024-05 | IN-VITRO AND IN-SILICO STUDIES FOR VARIOUS BIOTECHNOLOGICAL ASPECTS OF VITEX NEGUNDO | SINGH, AYUSHI |
| 2024-05 | IN SILICO STUDY TO DETERMINE THE POTENTIAL OF ALLIUM SATIVM TO PREVENT ISCHEMIC STROKES | ARORA, SANYA |
| 2024-06 | IN SILICO ANALYSIS OF CARNOSIC ACID'S THERAPEUTIC POTENTIAL AS A MULTITARGET INHIBITOR AGAINST NIPAH VIRUS REPLICATION | GUPTA, AYUSHI |
| 2024-06 | ROLE OF SORL1GENE AND ITS PHARMACOLOGICAL INTERACTIONS IN ALZHEIMER'S DISEASE | SAHU, AKANKSHA |
| 2024-06 | REPURPOSING OF DRUGS FOR GLUTAMATE RECEPTOR IN HUNTINGTON’S DISEASE: A BIOINFORMATICS EXPEDITION | VERMA, SURBHI |
| 2024-06 | TARGETING TREM2: IN-SILICO STUDY OF INTERACTIONS WITH GUT MICROBIOTA BASED SUPPLEMENTS FOR ALZHEIMER’S DISEASE | SINGH, SUPRATI |
| 2024-06 | REPURPOSING PHYTOCHEMICALS FOR LRRK2 G2019S AND Α-SYNUCLEIN MODULATION IN PARKINSON’S DISEASE: A BIOINFORMATICS APPROACH | KAUR, PARNEET |
| 2024-06 | REVOLUTIONIZING CANCER THERAPY: REPURPOSING FDA- APPROVED DRUGS FOR ERK1(MAPK3) INHIBITION VIA INTEGRATED DOCKING AND SIMULATION STRATEGY | KUMAR, NISHANT |
| 2024-06 | SYNERGIZING IN-SILICO APPROACHES OF NATURAL PRODUCT-BASED DRUG DISCOVERY AND DRUG REPURPOSING TO TARGET STATS IN GLIOB | NANCY |
| 2024-06 | FROM DOCKING TO DYNAMICS: REPURPOSING FDA-APPROVED DRUGS AS USP13 INHIBITORS FOR PARKINSON'S DISEASE | ASHISH |
| 2024-06 | EXPLORING PHYTOCHEMICALS FOR PARKINSON'S THERAPEUTICS THROUGH IN-SILICO DRUG DISCOVERY AND REPURPOSING T0 TARGET VPS35 AND ALPHA-SYNUCLEIN | ROY, ANJALI |
| 2024-06 | IN SILICO ANALYSIS OF MICROBIAL ENZYMES FOR DEGRADATION OF BISPHENOL A (BPA) AND ITS DERIVATIVES | SURBHI |
| 2024-05 | CHARACTERISATION OF RICTOR’S ROLE IN Caenorhabditis elegans | RAINA, SMRITI |
| 2024-06 | DISCOVERING GINKGO BILOBA PHYTOCHEMICALS AS THERAPEUTIC APPROACH FOR PARKINSON’S DISEASE: IN SILICO MOLECULAR DOCKING | SRIVASTAVA, SHIVANI |
| 2024-06 | SMOKING-INDUCED GENETIC DRIVERS OF LATENT TUBERCULOSIS REACTIVATION UNVEILED BY SINGLE-CELL RNA SEQUENCING ANALYSIS | SEHGAL, ISHITA |
Collection's Items (Sorted by Submit Date in Descending order): 61 to 80 of 201
